Publication | Open Access
Neutrophil‐to‐lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib
95
Citations
38
References
2020
Year
NLR can be associated with outcomes in patients with HCC treated with lenvatinib.
| Year | Citations | |
|---|---|---|
Page 1
Page 1